How to Use the USP–NF Errata Table

  • Searching: Type keyword in search field at top of page. Search by all or part of a monograph title. For searches using multiple criteria, you will find items that match each of the specified criteria unless quotation marks are used.
    • For example, a search on Aminosalicylic Acid Tablets will result in anything that contains “Aminosalicyclic” OR “Acid” OR “Tablets”
    • A search for “Aminosalicylic Acid Tablets” will result in anything that specifically contains “Aminosalicylic Acid Tablets”
  • Sorting: Click on any blue column header title to sort alphabetically or chronologically in ascending or descending order. Note: the page load column is sorted alphabetically so that a number is ordered by first digit vs. by the actual number; thus, numbers will not always be in order.
    • For example, page 2178 will come before page 74 on a page sort.
  • Downloading: You can download the Errata table in Comma-separated Value (.csv) or Excel format (.xls). The download will include all Errata from the database.
  • Printing: The table will print the view of the data as it has been filtered or sorted. To print a table of all Errata in the database, clear any keyword searches you have applied and select “Show: All”.
Monograph Title Section Source Publication Page Numbersort icon Errata Post Date Errata Official Date Target Errata Print Publication Target Online Fix Publication Description
DESCRIPTION AND SOLUBILITY Ethylcellulose Dispersion Type B USP35–NF30 1118 28-Sep-2012 01-Oct-2012 USP37–NF32 First Supplement to USP36–NF31
Lines 3 and 4: Change
in toluene, in chloroform, and in ethyl acetate; insoluble in water, in glycerin, and in propylene glycol.
to:
in tetrahydrofuran, and in ethyl acetate; insoluble in water and in chloroform.

Lines 3 and 4: Change

in toluene, in chloroform, and in ethyl acetate; insoluble
in water, in glycerin, and in propylene glycol.

to:

in tetrahydrofuran, and in ethyl acetate; insoluble in
water and in chloroform.
POWDERED BLACK PEPPER EXTRACT DEFINITION USP36–NF31 1365 29-Mar-2013 01-Apr-2013 USP37–NF32 USP37–NF32
Line 5: Change
It contains NLT 90.0% and NMT 110.0% of the labeled amount of piperine.
to:
It contains NLT 90.0% and NMT 110.0% of the labeled amount of piperine, calculated on the dried basis.

Line 5: Change
It contains NLT 90.0% and NMT 110.0% of the labeled amount of piperine.
to:
It contains NLT 90.0% and NMT 110.0% of the labeled amount of piperine, calculated on the dried basis.
ACESULFAME POTASSIUM IMPURITIES/Limit of Fluoride USP35–NF30 1680 31-Jan-2013 01-Feb-2013 USP37–NF32 Second Supplement to USP36–NF31
Line 25 of Analysis: Change
C = concentration of fluoride in the Sample solution, from the standard curve (mg/mL)
to:
C = concentration of fluoride in the Sample solution, from the standard curve (µg/mL)

Line 25 of Analysis: Change
C = concentration of fluoride in the Sample solution, from the standard curve (mg/mL)
to:
C = concentration of fluoride in the Sample solution, from the standard curve (µg/mL)
BENTONITE IDENTIFICATION/A. X-Ray Diffraction <941> USP35–NF30 1705 28-Sep-2012 01-Oct-2012 USP37–NF32 First Supplement to USP36–NF31
Line 4 of Acceptance criteria: Change
from the pattern of Sample B is 1.492 and 1.504 Å.
to:
from the pattern of Sample B is between 1.492 and 1.504 Å.

Line 4 of Acceptance criteria: Change

from the pattern of Sample B is 1.492 and 1.504 Å.

to:

from the pattern of Sample B is between 1.492 and
1.504 Å.
TRIBASIC CALCIUM PHOSPHATE IDENTIFICATION/Test A USP35–NF30 1719 28-Sep-2012 01-Oct-2012 USP37–NF32 First Supplement to USP36–NF31
Line 1 of the Sample solution: Change
Dissolve 100 mg in 5 mL of diluted nitric acid.
to:
A solution in a slight excess of nitric acid

Line 1 of the Sample solution: Change

Dissolve 100 mg in 5 mL of diluted nitric acid.

to:

A solution in a slight excess of nitric acid
CALCIUM SULFATE ASSAY/Procedure USP35–NF30 1724 28-Sep-2012 01-Oct-2012 USP37–NF32 First Supplement to USP36–NF31
Line 5 of Titrimetric system: Delete the subsection
Blank: 100 mL of water and 4 mL of 3 N hydrochloric acid
AND
Line 11 of Analysis: Delete the sentence
Perform a blank determination.
AND
Line 13 of Analysis: Change
Result = [(V − B) × N × F × 100]/W
to:
Result = [(V × N × F)/W] × 100
AND
Line 15 of Analysis: Delete
B = volume of titrant consumed by the Blank (mL)

Line 5 of Titrimetric system: Delete the subsection
Blank: 100 mL of water and 4 mL of 3 N hydrochloric
acid

AND
Line 11 of Analysis: Delete the sentence

Perform a blank determination.

AND
Line 13 of Analysis: Change

Result = [(V − B) × N × F × 100]/W
to:

Result = [(V × N × F)/W] × 100

AND
Line 15 of Analysis: Delete

B = volume of titrant consumed by the Blank (mL)
CALCIUM SULFATE SPECIFIC TESTS/Loss on Drying <731> USP35–NF30 1724 29-Mar-2013 01-Apr-2013 USP37–NF32 USP37–NF32
Line 1 of Acceptance criteria: Change
NMT 1.5% for the anhydrous form and NMT 19.0%–23.0% for the dihydrate
to:
NMT 1.5% for the anhydrous form and 19.0%–23.0% for the dihydrate

Line 1 of Acceptance criteria: Change
NMT 1.5% for the anhydrous form and NMT 19.0%–23.0% for the dihydrate
to:
NMT 1.5% for the anhydrous form and 19.0%–23.0% for the dihydrate
MICROCRYSTALLINE CELLULOSE IDENTIFICATION/B. Procedure USP35–NF30 1746 28-Sep-2012 01-Oct-2012 USP37–NF32 First Supplement to USP36–NF31
4th formula of Analysis: Change
Result = (95) × [η]c/WS × [(100 − %LOD)/100]
to:
Result = [(95) × [η]c]/{WS × [(100 − %LOD)/100]}

4th formula of Analysis: Change

Result = (95) × [η]c/WS × [(100 − %LOD)/100]

to:

Result = [(95) × [η]c]/{WS × [(100 − %LOD)/100]}
GLYCERYL BEHENATE IMPURITIES USP35–NF30 1811 31-Jan-2013 01-Feb-2013 USP37–NF32 Second Supplement to USP36–NF31
Line 34 of Content of 1-Monoglycerides/Analysis: Change
F = equivalency factor of glyceryl monobehenate, 207.3 mg/mEq
to:
F = equivalency factor of glyceryl monobehenate, 0.2073 g/mEq
AND
Line 19 of Limit of Free Glycerin/Analysis: Change
F = equivalency factor of glycerin, 23.0 mg/mEq
to:
F = equivalency factor of glycerin, 0.023 g/mEq

Line 34 of Content of 1-Monoglycerides/Analysis: Change
F = equivalency factor of glyceryl monobehenate, 207.3 mg/mEq

to:
F = equivalency factor of glyceryl monobehenate, 0.2073 g/mEq

AND
Line 19 of Limit of Free Glycerin/Analysis: Change
F = equivalency factor of glycerin, 23.0 mg/mEq
to:
F = equivalency factor of glycerin, 0.023 g/mEq
GLYCERYL MONOOLEATE SPECIFIC TESTS/Fats and Fixed Oils, Fatty Acid Composition <401> USP35–NF30 1814 31-Jan-2013 01-Feb-2013 USP37–NF32 Second Supplement to USP36–NF31
Column 3 of Table 1: Change in Row 1
Percentage, NMT (%)
to:
Percentage (%)
Change in Row 2
12.0
to:
NMT 12.0
Change in Row 3
6.0
to:
NMT 6.0
Change in Row 4
60.0
to:
NLT 60.0
Change in Row 5
35.0
to:
NMT 35.0
Change in Row 6
2.0
to:
NMT 2.0
Change in Row 7
2.0
to:
NMT 2.0
Change in Row 8
2.0
to:
NMT 2.0

Column 3 of Table 1: Change in Row 1
Percentage, NMT (%)
to:
Percentage (%)
Change in Row 2
12.0
to:
NMT 12.0
Change in Row 3
6.0
to:
NMT 6.0
Change in Row 4
60.0
to:
NLT 60.0
Change in Row 5
35.0
to:
NMT 35.0
Change in Row 6
2.0
to:
NMT 2.0
Change in Row 7
2.0
to:
NMT 2.0
Change in Row 8
2.0
to:
NMT 2.0
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE Assay USP35–NF30 1822 31-Jan-2013 01-Feb-2013 USP37–NF32 Second Supplement to USP36–NF31
Line 2: Change
Hypromellose 2906, except to substitute Low-Substituted Hydroxypropyl Cellulose for Hypromellose 2906 throughout.
to:
Hypromellose, except to substitute Low-Substituted Hydroxypropyl Cellulose for Hypromellose throughout.

Line 2: Change
Hypromellose 2906, except to substitute Low-Substituted Hydroxypropyl Cellulose for Hypromellose 2906 throughout.

to:
Hypromellose, except to substitute Low-Substituted Hydroxypropyl Cellulose for Hypromellose throughout.
MAGNESIUM STEARATE IMPURITIES/Chloride and Sulfate, Sulfate <221> USP35–NF30 1847 28-Sep-2012 01-Oct-2012 USP37–NF32 First Supplement to USP36–NF31
Line 3: Change
0.020 N sulfuric acid (1.0%)
to:
0.020 M sulfuric acid (1.0%)

Line 3: Change

0.020 N sulfuric acid (1.0%)

to:

0.020 M sulfuric acid (1.0%)
METHYL ALCOHOL ASSAY/Procedure USP35–NF30 1865 28-Sep-2012 01-Oct-2012 USP37–NF32 First Supplement to USP36–NF31
Line 9 of System suitability: Change
Tailing factor: NLT 1.5 for methyl alcohol, System suitability solution
to:
Tailing factor: NMT 1.5 for methyl alcohol, System suitability solution

Line 9 of System suitability: Change

Tailing factor: NLT 1.5 for methyl alcohol, System
suitability solution
to:

Tailing factor: NMT 1.5 for methyl alcohol, System
suitability solution
MYRISTYL ALCOHOL SPECIFIC TESTS/Fats and Fixed Oils, Hydroxyl Value <401> USP35–NF30 1873 31-Jan-2013 01-Feb-2013 USP37–NF32 Second Supplement to USP36–NF31
Line 7 of Analysis: Change
Result = [(VU − VB) × F]/W
VU = volume of 1 N sodium hydroxide consumed by the Sample (mL)
VB = volume of 1 N sodium hydroxide consumed by the Blank (mL)
to:
Result = [(VB − VU) × F]/W
VB = volume of 1 N sodium hydroxide consumed by the Blank (mL)
VU = volume of 1 N sodium hydroxide consumed by the Sample (mL)

Line 7 of Analysis: Change
Result = [(VU − VB) × F]/W
VU = volume of 1 N sodium hydroxide consumed by the Sample (mL)
VB = volume of 1 N sodium hydroxide consumed by the Blank (mL)
to:
Result = [(VB − VU) × F]/W
VB = volume of 1 N sodium hydroxide consumed by the Blank (mL)
VU = volume of 1 N sodium hydroxide consumed by the Sample (mL)
POLYETHYLENE OXIDE IMPURITIES/Organic Impurities/Procedure: Limit of Free Ethylene Oxide USP35–NF30 1906 28-Sep-2012 01-Oct-2012 USP37–NF32 First Supplement to USP36–NF31
Line 2 of System suitability: Change
Samples: Standard stock solution and Standard solution C
to:
Sample: Standard solution C

Line 2 of System suitability: Change

Samples: Standard stock solution and Standard solution
C
to:

Sample: Standard solution C
POLYSORBATE 20 SPECIFIC TESTS/Acid Value USP35–NF30 1919 28-Sep-2012 01-Oct-2012 USP37–NF32 First Supplement to USP36–NF31
Line 1 of Sample: Change
10.0
to:
10.0 g

Line 1 of Sample: Change

10.0

to:

10.0 g
Polysorbate 80 SPECIFIC TESTS/Fats and Fixed Oils, Saponification Value <401> USP35–NF30 1920 30-Nov-2012 01-Dec-2012 USP37–NF32 Second Supplement to USP36–NF31
Line 3 of Analysis: Change
0.5 N alcoholic potassium hydroxide
to:
0.5 N alcoholic potassium hydroxide VS

Line 6 of Analysis: Change
0.5 N hydrochloric acid
to:
0.5 N hydrochloric acid VS

Line 3 of Analysis: Change
0.5 N alcoholic potassium hydroxide
to:
0.5 N alcoholic potassium hydroxide VS

Line 6 of Analysis: Change
0.5 N hydrochloric acid

to:
0.5 N hydrochloric acid VS
Polysorbate 80 SPECIFIC TESTS/Fats and Fixed Oils, Hydroxyl Value <401> USP35–NF30 1920 30-Nov-2012 01-Dec-2012 USP37–NF32 Second Supplement to USP36–NF31
Line 13 of Analysis: Change
0.5 N alcoholic potassium hydroxide
to:
0.5 N alcoholic potassium hydroxide VS

Line 13 of Analysis: Change
0.5 N alcoholic potassium hydroxide
to:
0.5 N alcoholic potassium hydroxide VS
Polysorbate 80 SPECIFIC TESTS/Fats and Fixed Oils, Peroxide Value <401> USP35–NF30 1920 30-Nov-2012 01-Dec-2012 USP37–NF32 Second Supplement to USP36–NF31
Line 5 of Analysis: Change
0.01 M sodium thiosulfate
to:
0.01 M sodium thiosulfate VS

Line 5 of Analysis: Change
0.01 M sodium thiosulfate
to:
0.01 M sodium thiosulfate VS
POLYSORBATE 60 SPECIFIC TESTS/Acid Value USP35–NF30 1920 28-Sep-2012 01-Oct-2012 USP37–NF32 First Supplement to USP36–NF31
Line 1 of Sample: Change
10.0
to:
10.0 g

Line 1 of Sample: Change

10.0

to:

10.0 g
SODIUM HYDROXIDE ASSAY/Procedure USP35–NF30 1955 28-Sep-2012 01-Oct-2012 USP37–NF32 First Supplement to USP36–NF31
Line 10 of Analysis: Change
Result = {[(VS1 − VB) × N × F1]/W} × 100
to:
Result = {[(VS2 − VB) × N × F1]/W} × 100
AND
Line 11 of Analysis: Change
VS1
to:
VS2

Line 10 of Analysis: Change

Result = {[(VS1 − VB) × N × F1]/W} × 100

to:

Result = {[(VS2 − VB) × N × F1]/W} × 100

AND
Line 11 of Analysis: Change

VS1
to:

VS2
TAPIOCA STARCH Limit of oxidizing substances USP35–NF30 1987 29-Mar-2013 01-Apr-2013 USP37–NF32 USP37–NF32
Line 8: Change
Add 1 mL of starch TS, and titrate with 0.002 N sodium thiosulfate VS to the disappearance of the starch–iodide color.
to:
Add 1 mL of starch TS, and titrate with 0.002 N sodium thiosulfate VS to the disappearance of the starch–iodine color.

Line 8: Change
Add 1 mL of starch TS, and titrate with 0.002 N sodium thiosulfate VS to the disappearance of the starch–iodide color.
to:
Add 1 mL of starch TS, and titrate with 0.002 N sodium thiosulfate VS to the disappearance of the starch–iodine color.
DIETHYL SEBACATE DEFINITION USP36–NF31 1994 29-Mar-2013 01-Apr-2013 USP37–NF32 USP37–NF32
Line 2: Change
Diethyl Sebacate consists of the diester of alcohol and sebacic acid.
to:
Diethyl Sebacate consists of the diester of alcohol (ethanol) and sebacic acid.

Line 2: Change
Diethyl Sebacate consists of the diester of alcohol and sebacic acid.
to:
Diethyl Sebacate consists of the diester of alcohol (ethanol) and sebacic acid.
TREHALOSE ADDITIONAL REQUIREMENTS/USP Reference Standards <11> USP35–NF30 2007 28-Sep-2012 01-Oct-2012 USP37–NF32 First Supplement to USP36–NF31
Line 2: Delete
USP Glycerin RS

Line 2: Delete

USP Glycerin RS
ZEIN IDENTIFICATION/C. SDS-Polyacrylamide Gel Electrophoresis USP35–NF30 2019 28-Sep-2012 01-Oct-2012 USP37–NF32 First Supplement to USP36–NF31
Lines 1 and 2 of the Acceptance criteria: Change
Zein has two major bands: the α band is at 21–25 kDa, and the β band is at 17–18 kDa.
to:
Zein has two major bands for α-zein at 19–26 kDa.

Lines 1 and 2 of the Acceptance criteria: Change

Zein has two major bands: the α band is at 21–25
kDa, and the β band is at 17–18 kDa.

to:

Zein has two major bands for α-zein at 19–26 kDa.
HYMETELLOSE IMPURITIES/Chloride and Sulfate, Chloride <221> USP36–NF31 2044 29-Mar-2013 01-Apr-2013 USP37–NF32 USP37–NF32
Change the subsection title
Standard solution
to:
Control solution
AND
Line 4 of Analysis: Change
Standard solution
to:
Control solution
AND
Line 2 of Acceptance criteria: Change
Standard solution
to:
Control solution

Change the subsection title
Standard solution
to:
Control solution
AND
Line 4 of Analysis: Change
Standard solution
to:
Control solution
AND
Line 2 of Acceptance criteria: Change
Standard solution
to:
Control solution
INOSITOL SPECIFIC TESTS/Conductivity USP36–NF31 2049 29-Mar-2013 01-Apr-2013 USP37–NF32 USP37–NF32
Line 1 of Sample solution: Change
Transfer 10.0 g of Inositol, weighed and calculated on the dried basis, to a 50-mL volumetric flask, and dissolve in and dilute with water (previously boiled and cooled to room temperature) to volume.
to:
0.2 g/mL of Inositol in water (previously boiled and cooled to room temperature).

Line 1 of Sample solution: Change
Transfer 10.0 g of Inositol, weighed and calculated on the dried basis, to a 50-mL volumetric flask, and dissolve in and dilute with water (previously boiled and cooled to room temperature) to volume.

to:
0.2 g/mL of Inositol in water (previously boiled and cooled to room temperature).
ACETAZOLAMIDE FOR INJECTION ASSAY USP35–NF30 2063 28-Sep-2012 01-Oct-2012 USP37–NF32 First Supplement to USP36–NF31
Line 19: Change
25C(AU/AS)
to:
250C(AU/AS)

Line 19: Change
25C(AU/AS)

to:
250C(AU/AS)
ADENOSINE IDENTIFICATION/Infrared Absorption <197M> USP35–NF30 2079 28-Sep-2012 01-Oct-2012 USP37–NF32 First Supplement to USP36–NF31
Line 1:
Delete NMT 0.1%

Line 1:
Delete
NMT 0.1%
ALPRAZOLAM ORALLY-DISINTEGRATING TABLETS IMPURITIES/Procedure USP35–NF30 2106 28-Sep-2012 01-Oct-2012 USP37–NF32 First Supplement to USP36–NF31
Change the subsection
Buffer and Diluent: Prepare as directed in the Assay.
to:
Diluent: Prepare as directed in the Assay.
Buffer: 6.8 g/L of monobasic potassium phosphate in water. Adjust with phosphoric acid to a pH of 3.0.

Change the subsection

Buffer and Diluent: Prepare as directed in the Assay.

to:

Diluent: Prepare as directed in the Assay.

Buffer: 6.8 g/L of monobasic potassium phosphate in
water. Adjust with phosphoric acid to a pH of 3.0.
HYDROGENATED POLYDECENE ASSAY/Content of Decene Oligomer USP36–NF31 2133 29-Mar-2013 01-Apr-2013 USP37–NF32 USP37–NF32
Line 3 of System suitability: Change
[Note—The retention time for squalene is about 18 min; the relative retention times for tetradecane, hexadecane, and squalene are about 0.5, 0.6, and 1.0, respectively.]
to:
[Note—The retention time for squalane is about 18 min; the relative retention times for tetradecane, hexadecane, and squalane are about 0.5, 0.6, and 1.0, respectively.]

Line 3 of System suitability: Change
[Note—The retention time for squalene is about 18 min; the relative retention times for tetradecane, hexadecane, and squalene are about 0.5, 0.6, and 1.0, respectively.]

to:
[Note—The retention time for squalane is about 18 min; the relative retention times for tetradecane, hexadecane, and squalane are about 0.5, 0.6, and 1.0, respectively.]
AMANTADINE HYDROCHLORIDE CAPSULES PERFORMANCE TESTS/Dissolution <711>/Test 2 USP35–NF30 2153 31-Jan-2013 01-Feb-2013 USP37–NF32 Second Supplement to USP36–NF31
Line 5 of Chromatographic system: Change
Column: 0.32-mm × 30-cm, 0.25-μm film, phase G1
to:
Column: 0.32-mm × 30-m, 0.25-μm film, phase G1

Line 5 of Chromatographic system: Change
Column: 0.32-mm × 30-cm, 0.25-μm film, phase G1

to:
Column: 0.32-mm × 30-m, 0.25-μm film, phase G1
POLYVINYL ACETATE PHTHALATE IMPURITIES/Free Phthalic Acid USP36–NF31 2168 29-Mar-2013 01-Apr-2013 USP37–NF32 USP37–NF32
Line 1 of Sample solution: Change
6 mg/mL of polyvinyl acetate
to:
6 mg/mL of polyvinyl acetate phthalate

Line 1 of Sample solution: Change
6 mg/mL of polyvinyl acetate
to:
6 mg/mL of polyvinyl acetate phthalate
Aminosalicylate Sodium Limit of m-aminophenol USP35–NF30 2177 30-Nov-2012 01-Dec-2012 USP37–NF32 Second Supplement to USP36–NF31
Line 1 of Test preparation: Change
Use the Assay preparation, prepared as directed in the Assay.
to:
Transfer about 69 mg of Aminosalicylate Sodium, accurately weighed, to a 100-mL low-actinic volumetric flask, add 50 mL of Mobile phase, and swirl to dissolve. Add 10.0 mL of Internal standard solution, dilute with Mobile phase to volume, and mix.

Line 1 of Test preparation: Change
Use the Assay preparation, prepared as directed in the Assay.
to:
Transfer about 69 mg of Aminosalicylate Sodium, accurately weighed, to a 100-mL low-actinic volumetric flask, add 50 mL of Mobile phase, and swirl to dissolve. Add 10.0 mL of Internal standard solution, dilute with Mobile phase to volume, and mix.
Aminosalicylate Sodium Tablets Limit of m-aminophenol USP35–NF30 2178 30-Nov-2012 01-Dec-2012 USP37–NF32 Second Supplement to USP36–NF31
Line 1 of Test solution: Change
Use the Assay preparation, prepared as directed in the Assay.
to:
Weigh and finely powder not fewer than 20 Tablets. Transfer an accurately weighed portion of the powder, equivalent to about 690 mg of aminosalicylate sodium, to a 100-mL low-actinic volumetric flask. Add 50 mL of Mobile phase, and shake for about 5 minutes. Dilute with Mobile phase to volume, and mix. Filter, and transfer 10.0 mL of the clear filtrate to a low-actinic, 100-mL volumetric flask containing 10.0 mL of Internal standard solution, dilute with Mobile phase to volume, and mix.

Line 1 of Test solution: Change
Use the Assay preparation, prepared as directed in the Assay.
to:

 Read More
Aminosalicylic Acid Tablets Limit of m-aminophenol USP35–NF30 2179 30-Nov-2012 01-Dec-2012 USP37–NF32 Second Supplement to USP36–NF31
Change the subsection:
Mobile phase and Internal standard solution—Prepare as directed in the Assay under Aminosalicylic Acid.
to:
Mobile phase—Prepare as directed in the Assay under Aminosalicylic Acid.
Internal standard solution—Prepare a solution of sulfanilamide in Mobile phase having a concentration of about 5 µg per mL.

Line 1 of Test solution: Change
Use the Assay preparation, prepared as directed in the Assay.
to:
Weigh and finely powder not fewer than 20 Tablets. Transfer an accurately weighed portion of the powder, equivalent to about 500 mg of aminosalicylic acid, to a 100-mL low-actinic volumetric flask. Add 50 mL of Mobile phase, and shake for about 5 minutes. Dilute with Mobile phase to volume, and mix. Filter, and transfer 10.0 mL of the clear filtrate to a 100-mL low-actinic volumetric flask containing 10.0 mL of Internal standard solution, dilute with Mobile phase to volume, and mix.

Change the subsection:
Mobile phase and Internal standard solution—Prepare as directed in the Assay under Aminosalicylic Acid.
to:

Mobile phase—Prepare as directed in the Assay under
Aminosalicylic Acid.
Internal standard solution—Prepare a solution of sulfanilamide
in Mobile phase having a concentration of
about 5 µg per mL.

Line 1 of Test solution: Change
Use the Assay preparation, prepared as directed in
the Assay.
to:

 Read More
PROPYLENE GLYCOL MONOLAURATE IMPURITIES/Limit of Propylene Glycol USP36–NF31 2180 29-Mar-2013 01-Apr-2013 USP37–NF32 USP37–NF32
Line 8 of Analysis: Change
Calculate the percentage of free propylene glycol in the portion of Propylene Glycol Monocaprylate taken:
to:
Calculate the percentage of free propylene glycol in the portion of Propylene Glycol Monolaurate taken:

Line 8 of Analysis: Change
Calculate the percentage of free propylene glycol in the portion of Propylene Glycol Monocaprylate taken:

to:
Calculate the percentage of free propylene glycol in the portion of Propylene Glycol Monolaurate taken:
AMOXICILLIN TABLETS PERFORMANCE TESTS USP35–NF30 2202 28-Sep-2012 01-Oct-2012 USP37–NF32 First Supplement to USP36–NF31
Line 4 of Analysis: Change
Result = (rU/rS) × (CS/L) × (D/V) × P × F × 100
to:
Result = (rU/rS) × (CS/L) × V × D × P × F × 100
AND
Transpose lines 12 and 13 of the variable definition list to match the order in the equation

Line 4 of Analysis: Change

Result = (rU/rS) × (CS/L) × (D/V) × P × F × 100

to:

Result = (rU/rS) × (CS/L) × V × D × P × F × 100
AND

Transpose lines 12 and 13 of the variable definition list to match the order in the equation
Ampicillin Sodium SPECIFIC TESTS/pH <791> USP35–NF30 2213 30-Nov-2012 01-Dec-2012 USP37–NF32 Second Supplement to USP36–NF31
Line 2: Change text of Sample solution from
10.0 mg/mL
to:
10.0 mg/mL of ampicillin

Line 2: Change text of Sample solution from
10.0 mg/mL
to:
10.0 mg/mL of ampicillin
ATROPINE SULFATE TABLETS Assay USP35–NF30 2272 29-Mar-2013 01-Apr-2013 USP37–NF32 USP37–NF32
Line 9 of Procedure: Change
RU and RS are as defined therein.
to:
RU and RS are the peak area ratios of atropine to homatropine.

Line 9 of Procedure: Change
RU and RS are as defined therein.
to:
RU and RS are the peak area ratios of atropine to homatropine.
AZITHROMYCIN IMPURITIES/Organic Impurities/Procedure 2 USP35–NF30 2279 29-Mar-2013 01-Apr-2013 USP37–NF32 USP37–NF32
Line 15 of Analysis: Change
CS = concentration of USP Azithromycin RS in the Standard solution (µg/mL)
to:
CS = concentration of USP Azithromycin RS in the Standard solution (mg/mL)
AND
Add after CU:
P = potency of USP Azithromycin RS (µg/mg of azithromycin)

Line 15 of Analysis: Change
CS = concentration of USP Azithromycin RS in the Standard solution (µg/mL)
to:
CS = concentration of USP Azithromycin RS in the Standard solution (mg/mL)
AND
Add after CU:
P = potency of USP Azithromycin RS (µg/mg of azithromycin)
BETAMETHASONE ORAL SOLUTION Identification/A: USP35–NF30 2336 29-Mar-2013 01-Apr-2013 USP37–NF32 USP37–NF32
Line 1: Change
A:
to:
A: Thin-Layer Chromatographic Identification Test <201>—

Line 1: Change
A:

to:
A:
Thin-Layer Chromatographic Identification Test <201>—
BRINZOLAMIDE Related compounds/Test 2 USP35–NF30 2385 29-Mar-2013 01-Apr-2013 USP37–NF32 USP37–NF32
Line 15 of Procedure: Change
relative retention time greater than 6.
to:
relative retention greater than 6.

Line 15 of Procedure: Change
relative retention time greater than 6.
to:
relative retention greater than 6.
Budesonide ASSAY/Procedure USP35–NF30 2394 30-Nov-2012 01-Dec-2012 USP37–NF32 Second Supplement to USP36–NF31
Line 2 of Acceptance criteria: Change
Epimer A: 40.0%–51.0% on the dried basis
to:
Epimer A: 40.0%–51.0%

Line 2 of Acceptance criteria: Change
Epimer A: 40.0%–51.0% on the dried basis

to:
Epimer A: 40.0%–51.0%
Dibasic Calcium Phosphate Dihydrate ASSAY USP35–NF30 2463 30-Nov-2012 01-Dec-2012 USP37–NF32 Second Supplement to USP36–NF31
Line 14 of Analysis: Change
W = Sample weight (mg)
to:
W = Sample weight (mg) in 20.0 mL of the Sample solution

Line 14 of Analysis: Change
W = Sample weight (mg)
to:
W = Sample weight (mg) in 20.0 mL of the Sample solution
Dibasic Calcium Phosphate Dihydrate IMPURITIES/Heavy Metals, Method I <231> USP35–NF30 2463 30-Nov-2012 01-Dec-2012 USP37–NF32 Second Supplement to USP36–NF31
Line 1 of Test preparation: Change
Warm 1.3 g with 3 mL of 3 N hydrochloric acid to completely dissolve.
to:
Warm 1.3 g with 3 mL of 3 N hydrochloric acid until no more dissolves.

Line 1 of Test preparation: Change
Warm 1.3 g with 3 mL of 3 N hydrochloric acid to completely dissolve.
to:
Warm 1.3 g with 3 mL of 3 N hydrochloric acid until no more dissolves.
Anhydrous Dibasic Calcium Phosphate ASSAY USP35–NF30 2464 30-Nov-2012 01-Dec-2012 USP37–NF32 Second Supplement to USP36–NF31
In line 14 of Analysis: Change
W = Sample weight (mg)
to:
W = Sample weight (mg) in 20.0 mL of the Sample solution

In line 14 of Analysis: Change
W = Sample weight (mg)
to:
W = Sample weight (mg) in 20.0 mL of the Sample solution
Anhydrous Dibasic Calcium Phosphate IMPURITIES/Heavy Metals, Method I <231> USP35–NF30 2464 30-Nov-2012 01-Dec-2012 USP37–NF32 Second Supplement to USP36–NF31
Line 1 of Test preparation: Change
Warm 1.3 g with 3 mL of 3 N hydrochloric acid to completely dissolve.
to:
Warm 1.3 g with 3 mL of 3 N hydrochloric acid until no more dissolves.

Line 1 of Test preparation: Change
Warm 1.3 g with 3 mL of 3 N hydrochloric acid to completely dissolve.

to:
Warm 1.3 g with 3 mL of 3 N hydrochloric acid until no more dissolves.
CAPTOPRIL ORAL SOLUTION Assay USP35–NF30 2477 31-Jan-2013 01-Feb-2013 USP37–NF32 Second Supplement to USP36–NF31
Line 1 of Mobile phase: Change
Prepare a filtered and degassed mixture of methanol and water (11:9) containing 0.5 mL of phosphoric acid.
to:
Methanol and water (55:45) containing 0.5 mL/L of phosphoric acid. Filter, and degas.

Line 1 of Mobile phase: Change
Prepare a filtered and degassed mixture of methanol and water (11:9) containing 0.5 mL of phosphoric acid.

to:
Methanol and water (55:45) containing 0.5 mL/L of phosphoric acid. Filter, and degas.
CAPTOPRIL ORAL SUSPENSION Assay USP35–NF30 2477 31-Jan-2013 01-Feb-2013 USP37–NF32 Second Supplement to USP36–NF31
Line 1 of Mobile phase: Change
Prepare a filtered and degassed mixture of methanol and water (11:9) containing 0.5 mL of phosphoric acid.
to:
Methanol and water (55:45) containing 0.5 mL/L of phosphoric acid. Filter, and degas.

Line 1 of Mobile phase: Change
Prepare a filtered and degassed mixture of methanol and water (11:9) containing 0.5 mL of phosphoric acid.

to:
Methanol and water (55:45) containing 0.5 mL/L of phosphoric acid. Filter, and degas.
XLS CSV